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Helper proteins for neuroendocrine secretion
The granins, known to be general constituents of neuroendocrine secretory
granules, are regulators of the proteolytic processing of peptide precursors
and promote their aggregation-mediated sorting into secretory granules.
Eukaryotic cells capable of regulated protein secretion -
the exocytotic release of proteins in response to a
stimulus - package some of their secretory proteins into
specific storage organelles, the secretory granules. In
doing so, these cells sort secretory proteins away from
others that are delivered to the cell surface via the consti-
tutive secretory pathway common to all eukaryotic cells
(Fig. 1) [1]. The selective aggregation/condensation of
'regulated', but not of 'constitutive', secretory proteins is
thought to be of crucial importance for this sorting
process in all types of regulated secretory cell [2].
Another characteristic of the regulated secretory pathway
- the generation of biologically active peptides by
specific proteolytic processing of inactive precursors at
sites usually characterized by basic amino acids -is
found only in certain types of regulated secretory cell,
primarily endocrine cells and neurons, referred to collec-
tively as neuroendocrine cells (reviewed recently in [3]).
The proteolytic processing of newly synthesized peptide
precursors does not usually start before they reach the last
subcompartment of the Golgi complex, the trans-Golgi
network, where the constitutive and regulated pathways
begin to diverge. But both the peptide precursors and
the endoproteases concerned are synthesized in the
rough endoplasmic reticulum (ER), and they travel
together to, and through, the Golgi complex into secre-
tory granules. How, then, do neuroendocrine cells pre-
vent premature cleavage of peptide precursors in the
proximal compartments of the secretory pathway? And,
given that cleavage of peptide precursors at certain sites
does occur in the trans-Golgi network (for example, see
[4]), how do neuroendocrine cells ensure that the result-
ing precursor fragments, or at least the relevant ones,
nevertheless participate in aggregation/condensation-
mediated sorting into secretory granules? In answer to
these two questions, recent evidence shows that mem-
bers of (or proteins related to) the granin family func-
tion as helper proteins in the regulation of proteolytic
processing and in sorting.
The granins - a family of neuroendocrine-specific proteins
in search of a function
The granins (also known as chromogranins/secreto-
granins) are a family of acidic, heat-stable, secretory pro-
teins of unresolved function that have long been known
to be widespread constituents of secretory granules in
neuroendocrine cells (see [5] and references therein). In
addition to the three classical granins, chromogranin A,
chromogranin B (secretogranin I) and secretogranin II,
other proteins have been proposed to belong to this
family, in particular 7B2 (secretogranin V) [5]. All these
proteins contain several pairs of basic amino-acid resi-
dues and are cleaved intracellularly at some of these
dibasic sites before secretion. This observation has been
taken as indicating the possibility that the granins them-
selves may be precursors of bioactive peptides (see [6]
and references therein).
Although peptide fragments derived from chromogranin
A (such as pancreastatin) and from secretogranin II
(secretoneurin) apparently exhibit some activity as
autocrine or paracrine regulators of secretion (see [6] and
references therein), most granin researchers suspect that
these effects reflect, at best, only one of the functions of
the granins [5]. Indeed, ever since the observation that
chromogranin A, chromogranin B and secretogranin II
have common properties led to the concept of the
granins as a family [7], it has been proposed that they
may function intracellularly in the regulated secretory
pathway, for example as helper proteins in the sorting of
peptide precursors [7] or as inhibitors of precursor pro-
cessing [8]. Recent observations by Martens and co-
workers [9,10] now establish a role for 7B2 in the control
of precursor processing.
7B2 prevents premature activation of the prohormone
convertase PC2
The 7B2 protein, discovered by Chr6tien, Seidah and
colleagues [11], is synthesized as an approximately
27 kilodalton (kD) polypeptide (referred to here as
uncleaved 7B2) and is then proteolytically processed in
the cell into an amino-terminal 21 kD form (referred to
as cleaved 7B2; see references in [9,10,12]). (We prefer
not to use the terms 7B2 precursor or pro-7B2 for the
uncleaved form, as this may give rise to the misconcep-
tion that cleaved 7B2 is the biologically relevant form of
the protein.) 7B2 has a widespread distribution in neuro-
endocrine cells that is very similar, if not identical, to that
of PC2, one of the pro-hormone/pro-neuropeptide-
converting endoproteases that are related to the bacterial
protease, subtilisin, and the yeast endoprotease, kex-2,
and that cleave precursors at dibasic sites [13,14].
Moreover, the expression of 7B2 and that of PC2 are
coordinately regulated.
An important clue that these correlations of expression
are not just coincidental came with the demonstration
that recombinant 7B2 inhibits the endoprotease activity
of PC2 in vitro [9]. In searching for the physiological
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confirmed that a complex forms between 7B2 and PC2,
extended these observations by showing that 7B2 also
does not bind to furin, PACE4 and PC5, three other
members of the subtilisin/kex-2-related endoprotease
family. Third, the association between 7B2 and PC2 is
between uncleaved 7B2 and the 75 kD inactive 'pro'
form of PC2, and seems to begin in the rough ER.
Finally, this association is lost concomitantly with the
processing of uncleaved 7B2 to the carboxy-terminally
truncated cleaved 7B2 (18 kD in Xenopus) and the con-
version of proPC2 to the active 69 kD enzyme (Fig. 1).
What is required for this liaison between 7B2 and the
PC2 endoprotease to occur? Where exactly in the secre-
tory pathway does it end? And what triggers the divorce?
The amino-terminal portion of 7B2 has some homology
to the chaperonins [10], the molecular "chaperones that
help proteins to fold" [15]. Perhaps this domain of 7B2
contributes to its association with pro-PC2, along with
the cluster of basic amino-acid residues at the cleavage
site of 7B2 that also seem to be critical for binding to
PC2 [12]. Furthermore, experiments with thapsigargin,
an inhibitor of the Ca2 + pump of the ER, suggest that
the Ca2+-rich milieu of this compartment is somehow
important for formation of the complex [12].
Fig. 1. Proteolytic processing, sorting and secretion of proteins in
neuroendocrine cells. Events involving proteins undergoing regu-
lated secretion are shown in green boxes, those undergoing con-
stitutive secretion in red and those undergoing constitutive-like
secretion in yellow. For details,see text. Note that the pathway of
constitutive-like secretion via the early endosome is hypotheti-
cal; the broken line from the early endosome to the trans-Golgi
network indicates a possible route for the recycling of membrane
protein (such as a sorting receptor) from the immature secretory
granule. Abbreviations: POMC, proopiomelanocortin; CgB,
chromogranin B; -LPH, 3-lipotropin; ACTH, adrenocortico-
tropin; IG, immature granule.
relevance of this inhibition, Martens and colleagues [10],
working with Xenopus intermediate pituitary gland,
recently reported the following intriguing observations.
First, 7B2 forms a physical complex with the PC2 pro-
tease in vivo. Second, the formation of this complex is
specific for PC2: 7B2 does not bind to the related
endoprotease PC1/PC3, nor does it inhibit its activity
in vitro [9]. Seidah, Chr6tien and colleagues [12], who
As for the site of dissociation of the complex, labelling of
neuroendocrine AtT-20 cells with radioactive sulphate,
which is incorporated into proteins in the trans-Golgi
network [16], reveals only uncleaved 7B2, but not
cleaved 7B2, after a 10 minute pulse, indicating that
cleavage of 7B2 does not occur before the newly synthe-
sized protein reaches the trans-Golgi network [17].
Cleavage of a proportion of the labelled 7B2 molecules
was observed after a 15 minute sulphate pulse [17]. As
sulphated proteins are known to begin leaving the trans-
Golgi network after 5 minutes of labelling, and they do
so with a half-time of around 5 minutes [18], it follows
that (unless the exit of 7B2 from the trans-Golgi net-
work is unusually slow) cleavage of 7B2 occurs soon
after the protein leaves the trans-Golgi network - in
immature secretory granules, rather than in the trans-
Golgi network itself (Fig. 1). This conclusion has also
been reached by Zhou and Mains [19]. Similar sul-
phate-labelling data have been reported for the endo-
protease PC2 - only proPC2 but not PC2 itself is
labelled after a 15 minute pulse [20]. Hence, the imma-
ture secretory granule seems to be the main compart-
ment where uncleaved 7B2 and pro-PC2 are cleaved,
and, as these cleavages coincide with dissociation of the
two proteins from each other [10] (which in the case of
PC2 is followed by activation), the immature granule is
also the site where active PC2 is liberated from 7B2 in
order to process peptide precursors (Fig. 1). (Even if the
available data were to reflect cleavage of 7B2 and activa-
tion of PC2 in the trans-Golgi network, these events
would take place so shortly before the exit of active PC2
from the trans-Golgi network that the main compart-
ment for PC2 action would nonetheless be the immature
secretory granule.)
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Dissociation of the 7B2-PC2 complex may be triggered
by the cleavage of 7B2, a process thought to be catalyzed
by furin or the furin-like..endoprotease, PACE4 [17].
Furin is expressed in constitutive as well as in regulated
secretory cells and, in the course of its passage from the
trans-Golgi network to the plasma membrane and back
[21], it may well utilize not only the constitutive, but also
the constitutive-like, pathway (Fig. 1); it will thus pass
through immature secretory granules.
The proteolytic processing of a given peptide hormone
or neuropeptide precursor at its various cleavage sites has
been known to occur in a strict temporal order, starting
(for some precursors) in the trans-Golgi network and
continuing in immature (and sometimes mature) secre-
tory granules (see below) [3,19]. Of the two major endo-
proteases mediating this processing [13,14], PC2 is
activated later in the secretory pathway than PC1/PC3
[19,20]. The reason for this delayed activation, which is
one important parameter in the temporal control of pre-
cursor processing, was unknown. The observations of
Martens and colleagues [10] offer an explanation, as they
suggest that the association of uncleaved 7B2 with
proPC2 in the rough ER provides a safeguard mechanism
to prevent premature activation of the PC2 endoprotease
in the secretory pathway. Starting from the definition that
a molecular chaperone "binds to and stabilizes an other-.
wise unstable conformer of another protein and by con-
trolled binding and release of the substrate protein
facilitates its switching between active/inactive confor-
mations" [15], Martens and colleagues [10] propose that
7B2, presumably through its amino-terminal domain,
exerts a chaperone-like action on pro-PC2 by "holding it
in an inactive form" during transport from the ER to the
trans-Golgi network (Fig. 1). This is an interesting
hypothesis which, however, requires additional work and
perhaps further definition of terms.
If uncleaved 7B2 were absent, PC2 activation, which is
thought to occur by autocatalytic cleavage [22], could
occur prematurely - for example, early in the trans-
Golgi network, where the milieu of low pH/high Ca2 +
[2] might already be permissive for self-activation of
PC2. In addition, the ability of uncleaved 7B2 to inhibit
PC2 activity, presumably through its carboxy-terminal
domain [9], might also be relevant in this context.
Switching off this protective mechanism via cleavage of
7B2 by an endoprotease (furin or PACE4) that acts, at
the earliest, very late in the trans-Golgi network, rep-
resents a clever way of timing the activation of PC2
to the appropriate compartment, namely the immature
secretory granule (Fig. 1).
Controlled activation of endoproteases, however, is not
the only task that neuroendocrine cells need to perform
in order to release properly processed peptides from
secretory granules. Another is to ensure that precursor
fragments generated in the trans-Golgi network by
endoproteases such as furin or PC1/PC3 are actually
sorted into immature secretory granules. As it turns out,
another member of the granin family, chromogranin B
[5], seems to operate in this process. Before briefly sum-
marizing these data, however, we should first consider
the two levels at which sorting of proteins into the regu-
lated secretory pathway occurs in neuroendocrine cells.
The regulated secretory pathway has two levels of sorting
The first level of sorting takes place in the trans-Golgi
network, where regulated secretory proteins segregate
from constitutive secretory proteins by selective aggrega-
tion (Fig. 1) [2]. This process, which gives rise to the
dense cores observed in the trans-Golgi network by elec-
tron microscopy, is thought to reflect the intrinsic ten-
dency of regulated - but not constitutive - secretory
proteins to self-associate upon reaching a critical concen-
tration and encountering the specific lumenal milieu of
the trans-Golgi network. The aggregates of regulated
secretory proteins are believed to interact, via defined
short sequences, with membrane components in the
trans-Golgi network - the postulated sorting receptors;
they are then enveloped by membrane, thereby extruding
most of the fluid phase containing constitutive secretory
proteins, and pinch off from the trans-Golgi network to
form immature secretory granules [2].
The second level of sorting occurs in the course of
maturation of immature secretory granules (Fig. 1). This
process involves the further condensation of the secretory
granule matrix and removal of excess membrane, and may
be accompanied by the fusion of several immature secre-
tory granules with each other [23-25]. During matura-
tion of the immature secretory granule, membrane
components such as sorting receptors are thought to be
removed via clathrin-coated, immature granule-derived
vesicles; this would have the beneficial side-effect that
proteins that do not remain with, or never were part of,
the aggregated/condensed secretory granule matrix
would also be removed. Such proteins include residual
constitutive secretory proteins and unwanted protein frag-
ments resulting from the proteolytic processing of precur-
sors (for example, the C-peptide of pro-insulin), which
then undergo constitutive-like secretion (Fig. 1) [24,25].
Chromogranin B promotes sorting of precursor fragments to
secretory granules
The multipeptide precursor pro-opiomelanocortin is an
example of a regulated secretory protein that undergoes,
firstly, proteolytic processing in a strict temporal order,
and, secondly, sorting at the levels of both the trans-
Golgi network and the immature secretory granule (see
[19] and references therein). In AtT-20 neuroendocrine
cells, pro-opiomelanocortin is cleaved in the trans-Golgi
network at the dibasic site corresponding to the carboxyl
terminus of adrenocorticotropin (ACTH), yielding an
amino-terminal 23 kD fragment (containing ACTH) and
the carboxy-terminal -lipotropin (-LPH) fragment.
This is followed by cleavage, in immature granules, of the
23 kD fragment at the dibasic site corresponding to the
amino terminus of ACTH, yielding an amino-terminal
16 kD fragment and ACTH itself (Fig. 1).
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In AtT-20 cells, packaging of the 23 kD fragment in the
trans-Golgi network into immature secretory granules
operates with only partial efficiency, so that a significant
proportion is secreted constitutively. We have exploited
this property to investigate a possible role of chromo-
granin B in peptide-precursor sorting. Overexpression of
chromogranin B doubles the efficiency with which the
23 kD fragment is sorted to immature secretory granules
and subsequently processed to ACTH, and it reduces the
constitutive-like secretion of the 16 kD fragment from
immature secretory granules (our unpublished observa-
tions) (Fig. 1). As in the case of 7B2 binding to the PC2
endoprotease, chromogranin B overexpression shows tar-
get specificity: the exit of -LPH from the trans-Golgi
network, which in AtT-20 cells is largely packaged into
constitutive secretory vesicles, is unaffected. We conclude
that chromogranin B functions as a helper protein in the
sorting of certain peptide precursor fragments to the
regulated secretory pathway.
Perspectives
How do peptide hormones and neuropeptides, which are
initially synthesized as parts of larger biologically inactive
precursors, end up properly processed in the secretory
granules of neuroendocrine cells? A few years ago, this
question was dominated by the characterization of the rel-
evant processing enzymes and by efforts to elucidate the
basic mechanisms underlying sorting to the regulated
pathway. Meanwhile, additional players, long known to be
part of the ensemble, have appeared on stage, and we are
beginning to understand their roles as helper proteins in
the sorting and processing events. But the complexity of
peptide-precursor handling by neuroendocrine cells makes
it a safe guess that we do not yet know the entire cast.
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